Trial Profile
Safety of long-term Vedolizumab therapy for Crohn's Disease and Ulcerative Colitis treatment, a retrospective chart review
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
- 17 Jan 2018 New trial record